TOPLINE: The use of bisphosphonates, particularly risedronate, in patients with osteoporosis is linked to a higher risk for acute angle closure but not open-angle glaucoma. METHODOLOGY: Researchers conducted a retrospective cohort study using a nationwide health claims database to assess whether the use of oral or intravenous bisphosphonates increased the risk for acute angle closure …
